A proteome-scale map of the SARS-CoV-2-human contactome
© 2022. The Author(s)..
Understanding the mechanisms of coronavirus disease 2019 (COVID-19) disease severity to efficiently design therapies for emerging virus variants remains an urgent challenge of the ongoing pandemic. Infection and immune reactions are mediated by direct contacts between viral molecules and the host proteome, and the vast majority of these virus-host contacts (the 'contactome') have not been identified. Here, we present a systematic contactome map of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with the human host encompassing more than 200 binary virus-host and intraviral protein-protein interactions. We find that host proteins genetically associated with comorbidities of severe illness and long COVID are enriched in SARS-CoV-2 targeted network communities. Evaluating contactome-derived hypotheses, we demonstrate that viral NSP14 activates nuclear factor κB (NF-κB)-dependent transcription, even in the presence of cytokine signaling. Moreover, for several tested host proteins, genetic knock-down substantially reduces viral replication. Additionally, we show for USP25 that this effect is phenocopied by the small-molecule inhibitor AZ1. Our results connect viral proteins to human genetic architecture for COVID-19 severity and offer potential therapeutic targets.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Nature biotechnology - 41(2023), 1 vom: 10. Jan., Seite 140-149 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
EC 3.4.19.12 |
|---|
| Anmerkungen: |
Date Completed 20.01.2023 Date Revised 20.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41587-022-01475-z |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347322565 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347322565 | ||
| 003 | DE-627 | ||
| 005 | 20240320232840.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41587-022-01475-z |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1337.xml |
| 035 | |a (DE-627)NLM347322565 | ||
| 035 | |a (NLM)36217029 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kim, Dae-Kyum |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A proteome-scale map of the SARS-CoV-2-human contactome |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 20.01.2023 | ||
| 500 | |a Date Revised 20.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s). | ||
| 520 | |a Understanding the mechanisms of coronavirus disease 2019 (COVID-19) disease severity to efficiently design therapies for emerging virus variants remains an urgent challenge of the ongoing pandemic. Infection and immune reactions are mediated by direct contacts between viral molecules and the host proteome, and the vast majority of these virus-host contacts (the 'contactome') have not been identified. Here, we present a systematic contactome map of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with the human host encompassing more than 200 binary virus-host and intraviral protein-protein interactions. We find that host proteins genetically associated with comorbidities of severe illness and long COVID are enriched in SARS-CoV-2 targeted network communities. Evaluating contactome-derived hypotheses, we demonstrate that viral NSP14 activates nuclear factor κB (NF-κB)-dependent transcription, even in the presence of cytokine signaling. Moreover, for several tested host proteins, genetic knock-down substantially reduces viral replication. Additionally, we show for USP25 that this effect is phenocopied by the small-molecule inhibitor AZ1. Our results connect viral proteins to human genetic architecture for COVID-19 severity and offer potential therapeutic targets | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Proteome |2 NLM | |
| 650 | 7 | |a USP25 protein, human |2 NLM | |
| 650 | 7 | |a Ubiquitin Thiolesterase |2 NLM | |
| 650 | 7 | |a EC 3.4.19.12 |2 NLM | |
| 700 | 1 | |a Weller, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Lin, Chung-Wen |e verfasserin |4 aut | |
| 700 | 1 | |a Sheykhkarimli, Dayag |e verfasserin |4 aut | |
| 700 | 1 | |a Knapp, Jennifer J |e verfasserin |4 aut | |
| 700 | 1 | |a Dugied, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Zanzoni, Andreas |e verfasserin |4 aut | |
| 700 | 1 | |a Pons, Carles |e verfasserin |4 aut | |
| 700 | 1 | |a Tofaute, Marie J |e verfasserin |4 aut | |
| 700 | 1 | |a Maseko, Sibusiso B |e verfasserin |4 aut | |
| 700 | 1 | |a Spirohn, Kerstin |e verfasserin |4 aut | |
| 700 | 1 | |a Laval, Florent |e verfasserin |4 aut | |
| 700 | 1 | |a Lambourne, Luke |e verfasserin |4 aut | |
| 700 | 1 | |a Kishore, Nishka |e verfasserin |4 aut | |
| 700 | 1 | |a Rayhan, Ashyad |e verfasserin |4 aut | |
| 700 | 1 | |a Sauer, Mayra |e verfasserin |4 aut | |
| 700 | 1 | |a Young, Veronika |e verfasserin |4 aut | |
| 700 | 1 | |a Halder, Hridi |e verfasserin |4 aut | |
| 700 | 1 | |a la Rosa, Nora Marín-de |e verfasserin |4 aut | |
| 700 | 1 | |a Pogoutse, Oxana |e verfasserin |4 aut | |
| 700 | 1 | |a Strobel, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Schwehn, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Roujia |e verfasserin |4 aut | |
| 700 | 1 | |a Rothballer, Simin T |e verfasserin |4 aut | |
| 700 | 1 | |a Altmann, Melina |e verfasserin |4 aut | |
| 700 | 1 | |a Cassonnet, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a Coté, Atina G |e verfasserin |4 aut | |
| 700 | 1 | |a Vergara, Lena Elorduy |e verfasserin |4 aut | |
| 700 | 1 | |a Hazelwood, Isaiah |e verfasserin |4 aut | |
| 700 | 1 | |a Liu, Betty B |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Pandiarajan, Ramakrishnan |e verfasserin |4 aut | |
| 700 | 1 | |a Dohai, Bushra |e verfasserin |4 aut | |
| 700 | 1 | |a Coloma, Patricia A Rodriguez |e verfasserin |4 aut | |
| 700 | 1 | |a Poirson, Juline |e verfasserin |4 aut | |
| 700 | 1 | |a Giuliana, Paolo |e verfasserin |4 aut | |
| 700 | 1 | |a Willems, Luc |e verfasserin |4 aut | |
| 700 | 1 | |a Taipale, Mikko |e verfasserin |4 aut | |
| 700 | 1 | |a Jacob, Yves |e verfasserin |4 aut | |
| 700 | 1 | |a Hao, Tong |e verfasserin |4 aut | |
| 700 | 1 | |a Hill, David E |e verfasserin |4 aut | |
| 700 | 1 | |a Brun, Christine |e verfasserin |4 aut | |
| 700 | 1 | |a Twizere, Jean-Claude |e verfasserin |4 aut | |
| 700 | 1 | |a Krappmann, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Heinig, Matthias |e verfasserin |4 aut | |
| 700 | 1 | |a Falter, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Aloy, Patrick |e verfasserin |4 aut | |
| 700 | 1 | |a Demeret, Caroline |e verfasserin |4 aut | |
| 700 | 1 | |a Vidal, Marc |e verfasserin |4 aut | |
| 700 | 1 | |a Calderwood, Michael A |e verfasserin |4 aut | |
| 700 | 1 | |a Roth, Frederick P |e verfasserin |4 aut | |
| 700 | 1 | |a Falter-Braun, Pascal |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Nature biotechnology |d 1996 |g 41(2023), 1 vom: 10. Jan., Seite 140-149 |w (DE-627)NLM08998398X |x 1546-1696 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2023 |g number:1 |g day:10 |g month:01 |g pages:140-149 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41587-022-01475-z |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2023 |e 1 |b 10 |c 01 |h 140-149 | ||